Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lung Cancer Clinical Trials in Arizona | 544 Studies

Clinical Trials Lung CancerArizona

Lung Cancer Clinical Trials in Arizona

Find 544 clinical trials for lung cancer near Arizona. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 544 trials

CompletedA Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerThis multicenter, randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of RO5490258 (MetMab) in combination with either of two backbone…NCT01496742·Huntsville, Alabama and 86 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerRATIONALE: Studying samples of blood and tissue from smokers (closed to entry as of 7/15/07) and non-smokers with cancer in the laboratory may help doctors learn more about…NCT00450281·Anchorage, Alaska and 404 others

CompletedCombination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung CancerPhase 1b Dose Excalation/Expansion: Identify and characterize safety and tolerability of recommended phase 2 dose of CP-751,871 when administered with paclitaxel and carboplatin…NCT00147537·Tucson, Arizona and 30 others

CompletedPemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Pemetrexed disodium and sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00454194·Scottsdale, Arizona and 206 others

CompletedA Study to Evaluate Immunotherapy Combinations in Participants With Lung CancerThis is a Phase 1/1b, multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic, and clinical…NCT03846310·Tucson, Arizona and 21 others

CompletedA Study of Intravenous XMT-1001 in Patients With Advanced Solid TumorsThis amended expansion phase of the protocol is to further the experience at a dose level of 150 mg CPT eq/m2 in patients with Stage IV non-small cell lung cancer (NSCLC) and…NCT00455052·Scottsdale, Arizona and 11 others

CompletedNon-small Cell Lung Cancer Study US75 (Z-PACT)This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer.NCT00086268·Hoover, Alabama and 79 others

CompletedA Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsThis is an open-label, multicenter, multi-dose escalation and dose expansion study in subjects with selected advanced solid tumors (Part A) and advanced metastatic pancreatic…NCT04731467·Scottsdale, Arizona and 17 others

RecruitingA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerThe purpose of this study is to evaluate the efficacy and safety of divarasib and pembrolizumab compared with pembrolizumab and pemetrexed and carboplatin or cisplatin, for the…NCT06793215·Anchorage, Alaska and 287 others

TerminatedA Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung CancerA Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZD1775 plus antimitotic agent and Placebo plus an antimitotic agent in Previously Treated Non-Small-Cell…NCT02087176·Birmingham, Alabama and 11 others

CompletedA Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLCThe primary objective of this study will be to determine the progression free survival of patients with stage IIIb/IV non-small cell lung cancer (NSCLC) treated with dual agent…NCT00343291·Decatur, Alabama and 42 others

CompletedPhase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung CancerThe purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.NCT00040638·Tucson, Arizona and 2 others

CompletedPlatinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well platinum doublet chemotherapy and proton beam radiation therapy work in treating patients with stage II-III non-small cell lung…NCT03132532·Scottsdale, Arizona and 1 other

CompletedA Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1The goal of this clinical trial was to compare the efficacy and safety of anamorelin HCl (the investigational drug) to that of placebo (tablet with no drug) in patients with…NCT03743051·Tucson, Arizona and 71 others

RecruitingA Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerNon-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control.NCT07005102·Chandler, Arizona and 64 others

Active not recruitingErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerThis randomized phase II trial studies how well giving erlotinib hydrochloride and cabozantinib-s-malate alone or in combination works as second or third line therapy in treating…NCT01708954·Scottsdale, Arizona and 355 others

RecruitingA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II…NCT07169734·Phoenix, Arizona and 40 others

CompletedS9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004011·Birmingham, Alabama and 286 others

CompletedA Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneThis study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous…NCT00457392·Florence, Alabama and 203 others

TerminatedA Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)A randomized controlled trial comparing safety and efficacy of carboplatin and paclitaxel plus or minus sorafenib in chemonaive patients with stage III-IV non-small cell lung…NCT00300885·Birmingham, Alabama and 201 others

PreviousPage 6 of 28Next

Other Conditions in Arizona

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma